Peter Dieners
Head of Global Healthcare, Life Sciences and Chemicals Sector Group, Clifford Chance
Pharmaceutical and medical device law, law on advertising in the healthcare area, healthcare fraud and abuse prevention, healthcare-related commercial and corporate transactions.
Advises domestic and foreign corporations active in the fields of pharmaceuticals, medical devices, chemistry, food and cosmetics in all legal matters concerning the design, manufacturing and marketing of their products. Particularly advises manufacturers and distributors of pharmaceuticals and medical devices in regulatory, contractual, advertising, distribution and reimbursement matters.
Also regularly advises clients in domestic and cross-border healthcare-related transactions, healthcare-related commercial transactions including M&A partnering and R&D cooperative relationships. Advises on healthcare fraud and abuse investigation and prevention counselling. Acts for trade associations and companies vis-à-vis government agencies in relation to legislative projects and amendments.
Member of legal committees of the Federal Association of Pharmaceutical Manufacturers (BAH), the Federal Association of Medical Device Manufacturers (BVMed) and of Eucomed.
Admitted as a Lawyer in Germany 1992
Joined Clifford Chance 1994
Partner since 1997
Speaks German and English
1 blog from the author
Posted on 16.07.2012
Transparency in the HCP-Industry relationship: supporting industry efforts with an effective legal framework
For the medical technology industry, collaboration with healthcare professionals (HCPs) is an absolute must. HCPs are prime users of new technology and play an instrumental role in the successful diffusion of innovative medical devices throughout Europe. In fact, HCPs often bring the ideas to the table that lead to the development of new devices and inspire continuous incremental improvements to existing technology.
Medtech Views
Curated by
